
Mylorab D 30mg/20mg Capsule SR
Marketer
Realmed Pharma
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Mylorab D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD, or acid reflux) is effectively managed with the combination medication, Mylorab D 30mg/20mg sustained-release capsules. This treatment alleviates common GERD symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration for Mylorab D 30mg/20mg SR capsules are determined by your physician, and should be taken on an empty stomach. Treatment should continue as directed; premature cessation may lead to symptom recurrence and disease exacerbation. Inform your doctor of all other medications you are using, as interactions may occur. Common, usually transient side effects include diarrhea, abdominal discomfort, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or tasks requiring alertness until the drug's effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle changes, such as consuming cool milk and avoiding caffeinated beverages, spicy foods, and chocolate, can complement treatment. Prior to commencing therapy, disclose any kidney or liver conditions, and inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Primary Ingredients of Mylorab D 30mg/20mg Capsule SR
No text provided. Please provide the text you want me to rephrase.
Uses of Mylorab D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Mylorab D 30mg/20mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Mylorab D 30mg/20mg Sustained-Release Capsules should be administered on an empty stomach.
Common Side effects of Mylorab D 30mg/20mg Capsule SR:
- Pharyngitis
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Insomnia (difficulty in sleeping)
- Nausea
- Constipation
- Flatulence
- Nasal congestion (stuffy nose)
- Fundic gland polyps
- Back pain
How to use Mylorab D 30mg/20mg Capsule SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Consume Mylorab D 30mg/20mg sustained-release capsules on an empty stomach.
How Mylorab D 30mg/20mg Capsule SR works:
Mylorab D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. Domperidone, a prokinetic agent, enhances upper gastrointestinal motility, facilitating improved food passage through the stomach. Rabeprazole, a proton pump inhibitor (PPI), decreases gastric acid production, thereby alleviating acid indigestion and heartburn symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when drinking alcohol while taking Mylorab D 30mg/20mg sustained-release capsules. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Mylorab D 30mg/20mg SR capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
The prolonged-release Mylorab D 30mg/20mg capsule is likely unsuitable for breastfeeding mothers. Preliminary clinical evidence indicates potential drug transfer via breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Mylorab D 30mg/20mg sustained-release capsules might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
Exercise caution when prescribing Mylorab D 30mg/20mg sustained-release capsules to individuals with impaired renal function. Dosage modifications for Mylorab D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Mylorab D 30mg/20mg SR capsules to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician before use. Mylorab D 30mg/20mg SR capsules are contraindicated in patients exhibiting moderate to severe liver dysfunction.
What if you forget to take Mylorab D 30mg/20mg Capsule SR :
Should you forget to take a Mylorab D 30mg/20mg sustained-release capsule, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mylorab D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Digestive System |
